Join us for in-depth interviews with leading investors, entrepreneurs, researchers, and policymakers, pioneering a new future and healthcare with your host, Ross O'Brien, founder of Venture Capital firm, Bonaventure Venture Equity, author and lifelong entrepreneur. As an early investor in this new frontier, it's Ross's goal to share with you the conversations that he's having on an ongoing basis with the thought leaders and pioneers at this defining moment. We are in the midst of a mental health crisis, and an addiction crisis. Pain is an epidemic, and for the first time, we now have the legal pathways to develop psychedelic science to bring a new paradigm in medicine to the patients who need it most. As we imagine this new future, Ross is inspired every day by these visionaries and excited and privileged to introduce them to you.
Psychedelic Capital
Claim This Podcastby Ross O'Brien
Podcast Overview
Join us for in-depth interviews with leading investors, entrepreneurs, researchers, and policymakers, pioneering a new future and healthcare with your host, Ross O'Brien, founder of Venture Capital firm, Bonaventure Venture Equity, author and lifelong entrepreneur. As an early investor in this new frontier, it's Ross's goal to share with you the conversations that he's having on an ongoing basis with the thought leaders and pioneers at this defining moment. We are in the midst of a mental health crisis, and an addiction crisis. Pain is an epidemic, and for the first time, we now have the legal pathways to develop psychedelic science to bring a new paradigm in medicine to the patients who need it most. As we imagine this new future, Ross is inspired every day by these visionaries and excited and privileged to introduce them to you.
Language
🇺🇲
Publishing Since
2/5/2023
1 verified contact email on file for Psychedelic Capital
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
August 26, 2023
Navigating Regulatory Challenges and Ensuring Safety in the Psychedelics Industry
"Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape" The "Psychedelics Capital Podcast" host Ross O'Brien from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent. Produced by PodConx
July 6, 2023
Unleashing the Power of Psychedelics and AI: Revolutionizing Mental Health with Sensorium Therapeutics
Exploring the Potential of Psychedelics and Natural Compounds Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien from Bonaventure Equity to talk about co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Exploring the Potential of Psychedelics and Natural Compounds Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien from Bonaventure Equity to talk about co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies. Produced by PodConx Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/ Sensorium Therapeutics - https://www.sensorium.bio/
March 30, 2023
Cliché Busting: Navigating the Legal Challenges of the Cannabis and Psychedelic Industries
Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and psychedelic spaces. The conversation covers topics such as regulatory compliance, legal challenges, and unique challenges faced by emerging companies in these industries. Produced by PodConX Ross O'Brien - https://www.linkedin.com/in/rossobrien/ Bonaventure Equity - https://link.bve.vc/Visit-Us Jennifer Fisher - https://www.linkedin.com/in/jennifer-briggs-fisher-14843a/ Bill Growney - https://www.linkedin.com/in/billgrowney/ Goodwin Proctor - https://www.goodwinlaw.com/en
6 total episodes available
Deep-dive analytics for Psychedelic Capital
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Psychedelic Capital?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.